TrialRespiratory research2020

Metabolic and cardiorespiratory effects of decreasing lung hyperinflation with budesonide/formoterol in COPD: a randomized, double-crossover, placebo-controlled, multicenter trial.

Miguel J Divo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.